Rabies

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:770A82.0A82.1A82.9
Who is this for?
Show terms as
7Active trials45Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rabies is a fatal viral zoonotic disease caused by lyssaviruses, most commonly the rabies virus (RABV), belonging to the family Rhabdoviridae. The disease is transmitted to humans primarily through the bite or scratch of an infected animal, most often dogs, bats, raccoons, skunks, and foxes. The virus enters peripheral nerves at the wound site and travels to the central nervous system, where it causes progressive and almost invariably fatal encephalomyelitis. Rabies is classified under Orphanet code 770 and ICD-10 codes A82.0 (sylvatic rabies), A82.1 (urban rabies), and A82.9 (rabies, unspecified). The incubation period is highly variable, typically ranging from one to three months but can extend from days to over a year, depending on the site and severity of the bite and the viral load. The disease presents in two clinical forms: furious (encephalitic) rabies, which is more common and characterized by hyperactivity, hydrophobia (fear of water), aerophobia (fear of drafts), agitation, confusion, hallucinations, and autonomic dysfunction; and paralytic (dumb) rabies, which presents with ascending paralysis resembling Guillain-Barré syndrome. Both forms progress to coma and death, typically within days to weeks of symptom onset. Hydrophobia, caused by painful spasms of the pharyngeal and diaphragmatic muscles triggered by attempts to swallow, is considered pathognomonic for rabies. Once clinical symptoms appear, rabies is almost universally fatal, with only a handful of documented survivors worldwide. However, rabies is entirely preventable through timely post-exposure prophylaxis (PEP), which includes thorough wound washing, administration of rabies immunoglobulin, and a series of rabies vaccine doses. Pre-exposure prophylaxis vaccination is recommended for individuals at high risk, such as veterinarians, animal handlers, and travelers to endemic regions. Despite the availability of effective prevention, rabies causes an estimated 59,000 human deaths annually worldwide, predominantly in Asia and Africa, with most cases resulting from dog bites in resource-limited settings where access to PEP is inadequate.

Clinical phenotype terms— hover any for plain English:

Excessive salivationHP:0003781Recurrent pharyngitisHP:0100776InsomniaHP:0100785Vocal cord paresisHP:0001604
Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
May 2026Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.

Institute of Tropical Medicine, Belgium — PHASE3

TrialNOT YET RECRUITING
Mar 2026A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)

Changchun BCHT Biotechnology Co. — PHASE3

TrialENROLLING BY INVITATION
Mar 2026Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine

Sinovac Biotech Co., Ltd — PHASE3

TrialNOT YET RECRUITING
Mar 2026Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen

Sinovac Biotech Co., Ltd — PHASE3

TrialNOT YET RECRUITING
Mar 2026Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

Sinovac Biotech Co., Ltd — PHASE3

TrialNOT YET RECRUITING
Feb 2026A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried in a Population Aged 10 to 60 Years

Ab&B Bio-tech Co., Ltd.JS — PHASE3

TrialACTIVE NOT RECRUITING
Jan 2026A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody

Lanzhou Institute of Biological Products Co., Ltd — PHASE2

TrialNOT YET RECRUITING
Dec 2025Safety and Immunogenicity of ID vs IM Rabies Vaccine

International Centre for Diarrhoeal Disease Research, Bangladesh — PHASE2, PHASE3

TrialNOT YET RECRUITING
Dec 2025Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine

University of Oxford — PHASE2

TrialNOT YET RECRUITING
Sep 2025A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)

Changchun BCHT Biotechnology Co. — PHASE1

TrialENROLLING BY INVITATION

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Rabies.

7 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

7 recruitingView all trials with filters →
Phase 33 trials
A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried in a Population Aged 10 to 60 Years
Phase 3
Active
· Sites: Huanggang, Hubei; Shiyan, Hubei +3 more · Age: 1060 yrs
Prevention of Rabies With Four Doses of Rabies Vaccine
Phase 3
Enrolling by Invitation
PI: Li Miao (Changchun Zhuoyi Biological Co., Ltd) · Sites: Changchun, Jilin · Age: 1060 yrs
A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)
Phase 3
Enrolling by Invitation
· Sites: Neijiang, Sichuan · Age: 1060 yrs
Phase 13 trials
A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults
Phase 1
Actively Recruiting
· Sites: Antwerp; Ghent · Age: 1840 yrs
A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried
Phase 1
Actively Recruiting
· Sites: Zhengzhou, Henan · Age: 1060 yrs
A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)
Phase 1
Enrolling by Invitation
· Sites: Xuzhou, Jiangsu · Age: 1060 yrs

Specialists

Showing 25 of 45View all specialists →
YH
Yuemei Hu
Specialist
PI on 6 active trials424 Rabies publications
SP
Sowath LY, PhD
Specialist
PI on 1 active trial
TM
Thavatchai Kamoltham, MD
Specialist
PI on 1 active trial
SM
Suda Sibunruang, MD
Specialist
PI on 6 active trials
MM
Mark R. Withers, M.D., MPH
FREDERICK, MD
Specialist
PI on 1 active trial
WM
Waqar Ali, MPhil
BELLFLOWER, CA
Specialist
PI on 1 active trial
SM
Suda Sibunruang, M.D.
Specialist
PI on 1 active trial
XP
Xiaoqiang Liu, PHD
Specialist
PI on 1 active trial
DP
Darryn Knobel, PhD
Specialist
PI on 1 active trial
MM
Mahamadou A Thera, MD MPH
Specialist
PI on 2 active trials
NM
Nadine Rouphael, MD
ATLANTA, GA
Specialist
PI on 6 active trials
GP
Giuseppe Pantaleo
NEW YORK, NY
Specialist
PI on 2 active trials
MM
Mark Matson, M.D.
Specialist
PI on 2 active trials
RP
Rachel Presti, MD PhD
NAPLES, FL
Specialist
PI on 1 active trial
MM
Mark Polhemus, MD
ALBUQUERQUE, NM
Specialist
PI on 2 active trials
MM
Mahamadou A Thera, MD, MPH
Specialist
PI on 1 active trial
FS
Franz-Josef Falkner von Sonnenburg
Specialist
PI on 1 active trial
RZ
Ruizhi Zhang
Specialist
PI on 1 active trial
TE
Timothy Endy
SYRACUSE, NY
Specialist
PI on 1 active trial
TT
Terapong Tantawichien
Specialist
PI on 1 active trial
PP
Pham N Hung, As. Prof.
Specialist
PI on 1 active trial
GN
G Nagashayana
Specialist
PI on 1 active trial
MS
Michael Sirimaturos
Specialist
PI on 1 active trial
CH
Chaolin Huang
Specialist
PI on 1 active trial
PS
Patrick Soentjens
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rabies.

Search all travel grants →NORD Financial Assistance ↗

Community

Open RabiesForum →

No community posts yet. Be the first to share your experience with Rabies.

Start the conversation →

Latest news about Rabies

Disease timeline:

New recruiting trial: A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried

A new clinical trial is recruiting patients for Rabies

New recruiting trial: Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations

A new clinical trial is recruiting patients for Rabies

New recruiting trial: A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults

A new clinical trial is recruiting patients for Rabies

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rabies

What is Rabies?

Rabies is a fatal viral zoonotic disease caused by lyssaviruses, most commonly the rabies virus (RABV), belonging to the family Rhabdoviridae. The disease is transmitted to humans primarily through the bite or scratch of an infected animal, most often dogs, bats, raccoons, skunks, and foxes. The virus enters peripheral nerves at the wound site and travels to the central nervous system, where it causes progressive and almost invariably fatal encephalomyelitis. Rabies is classified under Orphanet code 770 and ICD-10 codes A82.0 (sylvatic rabies), A82.1 (urban rabies), and A82.9 (rabies, unspecif

Are there clinical trials for Rabies?

Yes — 7 recruiting clinical trials are currently listed for Rabies on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Rabies?

25 specialists and care centers treating Rabies are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.